“The duration & magnitude of #SARS2 immunity after infection, especially wrt the emergence of new VOCs”
1/
At 12 months after mild-COVID19:
1->90% of convalescents remained seropositive for RBD-IgG & 88.9% had circulating RBD-specific memory B cells.
2-Despite this, only 51.2% convalescents had serum neutralising activity against homologous live-SARS2 virus
2/
3-The neutralising activity decreased to 44.2% against live Alpha, 4.6% against Beta, 11.6% against Gamma & 16.2%, against Delta
4-Spike & non-Spike-specific T cells were detected in >50% of convalescents
3/
5- T cells frequency values were higher for S antigen compared to non-S antigens
6-Despite high prevalence & maintenance of S-specific T cells in convalescents at 12 mo, T cell functionality after stimulation with Sepitopes corresponding to VoC was severely affected
4/
Interpretation:
1-SARS2 immunity is retained in a significant proportion of mild #COVID19 convalescents 12 mo post-infection in the absence of re-exposure to the virus
5/
2-Despite this, changes in the amino acid sequence of Spike antigen that are present in current VoC result in virus evasion of neutralising antibodies, as well as evasion of functional T cell responses
3-Natural immunity may not protect you against new VOC including Delta
6/
4-A new wave can be started by the existing Delta variant still circulating here
5-One needs to avoid complacency! You don’t need a need a new variant to ignite a new surge in cases
What happens if we allow #SARS2 to become endemic? What’s going to happen to us & what’s going to happen to the virus?
If we allow it to become endemic—and some would argue that it is already endemic—this does not mean that it is going to attenuate, not whatsoever. 1/
It is not true that more transmissible versions of #SARS2 will be more benign. What we are seeing is more aggressive, more transmissible versions which are creating more severe illness. And the virus is still adapting to our physiology. It’s doing it at a fantastic rate 2/
What we’re going to see is that it will continue to work against our immune systems, meaning become more immune evasive. It’s going to become more chronic as an infection. 3/
Booster effectiveness against breakthrough coronavirus infection is already waning.
The protection against infection among Pfizer booster recipients ages 60+ topped out by day 30 then fell steadily. 1/
By day 58, the #booster appeared to be providing around 40% of the maximum increased level of protection above the initial 2-dose series.
New data finds boosters are helping more than just 50+, but that the effects already appear to be decreasing. 2/
Bottom line: The case for boosters to prevent infection for all adults is now far stronger, if that is our goal. But how long that protection lasts remains unclear at best and boosters may turn out to lower the #Ro of #SARS2 only briefly. 3/
1-Vaccination reduces transmission of #Delta, but by less than #Alpha
2-Alpha: Pfizer 62%, AZ 38% reduction
Delta: Pfizer 37%, AZ 15% reduction (aOR)
3-The impact of vaccination decreased over time 1/
4-Vaccinated people with breakthrough infections were less likely to spread Covid.
5-Vaccination not only reduces the risk of becoming seriously ill from the virus, it also protects those around you. 2/
6-Contacts of vaccinated cases were less likely get Covid than contacts of unvaccinated cases.
7-Most transmission occurred in households, showing that vaccination can protect household members—including kids not yet eligible for vaccination. 3/
No doubt, #molnupiravir is touted as a ‘game changer’ as far as therapeutics against #SARS2 are concerned. But the news related to its probable #mutagenic potential comes as a dampener 1/
#rNHC, an active metabolite of #Molnupiravir, inhibits SARS2 replication in cell cultures through lethal mutagenesis, but is also mutagenic to mammalian host cells 2/
#rNHC has powerful in vitro and in vivo activity against a large number of highly pathogenic emerging RNA viruses and represents a potentially important drug for use in the current and future pandemics. 3/
What might #Covid19 look like once the pandemic is over?
With #SARS2 it’s already clear that immunity from infection wanes..it might follow..in which protection from infection erodes over time, but protection from severe disease does not. So it would behave like COMMON COLD 1/
Or it’d be like #FLU, where immunity vs. severe disease also wanes. Influenza is a more sobering analogy. It, too, causes infections throughout life, but reinfections are often more severe than those caused by the four endemic coronaviruses. 2/
So, the outlook is different if immunity against severe #COVID declines as well. In that case paradoxically, it might be best if the virus keeps infecting people frequently... Avoiding infection at all costs might not be the best strategy for vaccinated people. 3/